Compugen to Participate in the JMP Securities C-Suite Series- TIGIT Landscape Overview

/PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, announced today...

Related Keywords

Israel ,Tel Aviv ,Yvonne Naughton ,Astrazeneca ,Compugen Ltd ,Corporate Communications ,Stock Exchange ,Compugen ,Prnewswire Compugen Ltd ,Nasdaq ,Anat Cohen Dayag ,C Suite Series ,Investor Relations ,South San Francisco ,